High Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality

被引:0
|
作者
Silbernagel, Guenther [1 ]
Pagel, Philipp [2 ]
Pfahlert, Volker [2 ]
Genser, Bernd [3 ,4 ,5 ]
Scharnagl, Hubert [6 ]
Kleber, Marcus E. [7 ]
Delgado, Graciela [7 ]
Ohrui, Haruna [8 ]
Ritsch, Andreas [9 ]
Grammer, Tanja B. [3 ]
Koenig, Wolfgang [10 ,11 ]
Maerz, Winfried [6 ,7 ,12 ,13 ]
机构
[1] Hosp Univ Graz, Dept Med Interna, Div Angiol, Graz, Austria
[2] Numares AG, Regensburg, Germany
[3] Heidelberg Univ, Fac Med Mannheim, Inst Salud Publ Med Social & Prevent, Mannheim, Germany
[4] Asesoria Estadist BG, Viena, Austria
[5] Univ Fed Bahia, Inst Salud Publ, Salvador, BA, Brazil
[6] Univ Med Graz, Lab Med & Quim, Inst Clin Diagnost Lab Med & Quim, Graz, Austria
[7] Heidelberg Univ, Fac Med Mannheim, Dept Med Interna Nefrol Hipertensiol Endocrinol D, Mannheim, Germany
[8] Skylight Biotech Inc, Akita, Japan
[9] Univ Med Innsbruck, Dept Med Interna Endocrinol & Metab 1, Innsbruck, Austria
[10] Univ Tecn Munich, Ctr Aleman Corazon, Dept Cardiol, Munich, Germany
[11] DZHK Ctr Aleman Invest Cardiovasc, Sitio Asociado Alianza Corazon Munich, Munich, Germany
[12] Serv Synlab GmbH, Acad Synlab, Mannheim, Germany
[13] Serv Synlab GmbH, Acad Synlab, Augsburg, Germany
来源
关键词
CHOLESTEROL EFFLUX; RISK PREDICTION; HDL; EVENTS; QUANTIFICATION; PROFILE; IDENTIFICATION; TRIGLYCERIDES; RELEVANCE; PATHWAYS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The inverse relationship between HDL cholesterol and cardiovascular mortality is weakened in coronary artery disease (CAD). We aimed to investigate the associations of HDL particle concentrations with cardiovascular mortality and the impact of CAD on these associations. We also sought to comparatively evaluate HDL cholesterol and HDL particle concentrations in predicting cardiovascular mortality. Methods: Total and subclass HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy in 2,290 participants of the LUdwigshafen RIsk and Cardiovascular Health study referred for coronary angiography. The participants were prospectively followed over a median (interquartile range) duration of 10.0 (6.1-10.6) years. Results: The mean (SD) age of the participants (1,575 males, 715 females) was 62.9 (10.4) years, body mass index 27.6 (4.1) kg/m(2), HDL cholesterol 39 (11) mg/dL [1 (0.29) mmol/L], and total HDL particle concentration 24.1 (5.8) mu mol/L. 434 persons died from cardiovascular diseases. In multivariate analyses, tertiles of total HDL particle concentrations were inversely related to cardiovascular mortality (HR for 3rd vs. 1st tertile = 0.55, P<0.001). This association was primarily mediated by small HDL particles (P<0.001). Adding total or small HDL particle concentrations rather than HDL cholesterol to multivariate prediction models improved performance metrics for cardiovascular mortality. The presence of CAD had no impact on the associations between HDL particle concentrations and cardiovascular mortality. Conclusions: High HDL particle concentration is consistently and independently of CAD associated with decreased cardiovascular mortality. Whether the inverse relationship between HDL particle concentration and cardiovascular mortality may be translated into novel therapies is under investigation.
引用
收藏
页码:97 / 108
页数:12
相关论文
共 50 条
  • [41] HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND CORONARY-ARTERY DISEASE - SURVEY OF THE EVIDENCE
    RIFKIND, BM
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (06): : A3 - A6
  • [42] EMPHASIS ON HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH CORONARY-ARTERY DISEASE
    MAILANDER, L
    LAVIE, CJ
    MILANI, RV
    GAUDIN, D
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (05) : 508 - 512
  • [43] High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease
    Yazdandoust, Shima
    Parizadeh, Seyyed Mohammad Reza
    Ghayour-Mobarhan, Majid
    Yaghmaei, Parichehreh
    Sahebkar, Amir Hossein
    BIOFACTORS, 2022, 48 (03) : 634 - 642
  • [44] Effects of simvastatin on the transfer of lipids to high density lipoprotein in coronary artery disease patients
    Lo Prete, A. C.
    Dina, C. H.
    Azevedo, C. H. M.
    Seydell, T. M.
    Hueb, W.
    Maranhao, C.
    CIRCULATION, 2008, 118 (12) : E221 - E221
  • [45] The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease
    Philippe Meyer
    Anil Nigam
    Michel Marcil
    Jean-Claude Tardif
    Current Atherosclerosis Reports, 2009, 11 : 329 - 333
  • [46] Pre beta(1)-high-density lipoprotein increases in coronary artery disease
    Miida, T
    Nakamura, Y
    Inano, K
    Matsuto, T
    Yamaguchi, T
    Tsuda, T
    Okada, M
    CLINICAL CHEMISTRY, 1996, 42 (12) : 1992 - 1995
  • [47] STATIN EFFECTS ON LIPIDS TRANSFER TO HIGH DENSITY LIPOPROTEIN IN CORONARY ARTERY DISEASE PATIENTS
    Lo Prete, A. C.
    Dina, C. H.
    Azevedo, C. H.
    Hueb, W.
    Lopes, N.
    Maranhao, R. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 196 - 196
  • [48] Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
    Katz, Pamela M.
    Leiter, Lawrence A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (06) : 667 - 677
  • [49] The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease
    Meyer, Philippe
    Nigam, Anil
    Marcil, Michel
    Tardif, Jean-Claude
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (05) : 329 - 333
  • [50] High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease
    Tornvall, P
    Karpe, F
    Proudler, A
    Bavenholm, P
    Landou, C
    Olivecrona, T
    Hamsten, A
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (11): : 1375 - 1382